SCHEMBL7893458

SCHEMBL7893458

CC(CCCc1ccccc1)n1ncc(C(N)=O)c1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK2 O43353 1/20 0.46
FAAH O00519 1/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
TSHR P16473 1/20 0.40
ALDH1A1 P00352 1/20 0.39
GRIK1 P39086 1/20 0.39
LMNA P02545 3/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ADRA1D P25100 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7885859 0.87 RIPK2 (0.43) RIPK2FAAHPDE4APDE4BPDE4C
SCHEMBL6996007 0.82 PDE4A (0.41) FAAHPDE4APDE4BPDE4CPDE4D
SCHEMBL7381725 0.81 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DGRIK1
SCHEMBL7378633 0.81 TSHR (0.49) PDE4APDE4BPDE4CPDE4DTSHR
SCHEMBL7361207 0.78 KMT2A (0.45) FAAHPDE4APDE4BPDE4CPDE4D
SCHEMBL6997571 0.77 ALDH1A1 (0.38) FAAHKMT2AMEN1TSHRALDH1A1
SCHEMBL27481625 0.76 L3MBTL1 (0.34) KMT2AMEN1TSHRLMNAL3MBTL1
SCHEMBL7893498 0.75 PDE2A (0.42) FAAHPDE4APDE4BPDE4CPDE4D
SCHEMBL7511580 0.75 LMNA (0.42) PDE4APDE4BPDE4CPDE4DKMT2A
SCHEMBL7843449 0.72 PDE4A (0.40) PDE4APDE4BPDE4CPDE4DKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1151155-C 1, 5-dihydro-pyrazolo [3, 4-D ] -pyrimidone derivatives 2004-05-26 CN disclosed
US-6174884-B1 CARDIOVASCULAR DISORDERS; CEREBROVASCULAR DISEASES; VASCULAR SYSTEM DISORDERS, ESPECIALLY THE PERIPHERAL BLOOD VESSELS; UROGENITAL DISORDERS; HYPOTENSIVE AGENTS; ANTIARRYTHMIA AND -ISCHEMIC AGENTS; PHOSPHODIESTERASE ACTIVITY BAYER AKTIENGESELLSCHAFT (DE) 2001-01-16 US disclosed
CN-1255133-A 1,5-dihydro-pyrazolo [3,4-D]-pyrimidinone derivatives BAYER AG (DE) 2000-05-31 CN disclosed